Moreover, the OS of patients with HCC and high FAT4 expression was prolonged, further suggesting that FAT4 has tumor suppressor effects in HCC and may serve as a novel prognostic biomarker. The gene discussed is FAT4; the disease is hepatocellular carcinoma.